How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
DNA Ginkgo Bioworks Holdings, Inc.
Welcome to the ADK Sample Agents repository! This collection provides ready-to-use agents built on top of the Agent Development Kit, designed to accelerate your development process. These agents cover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback